[Federal Register Volume 76, Number 82 (Thursday, April 28, 2011)]
[Notices]
[Page 23819]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-10257]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Prospective Granting of an Exclusive License

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This is a notice in accordance with 35 U.S.C. 209(e) and 37 
CFR 404.7(a)(1)(i) that the Technology Transfer Office of the Centers 
for Disease Control and Prevention (CDC), located within the Department 
of Health and Human Services (HHS), is contemplating granting a 
worldwide exclusive license to AES Raptor, LLC, located in North Kansas 
City, Missouri. Under this exclusive license, only AES Raptor, LLC 
would be permitted to commercialize the technology described in the 
patent applications listed below. CDC intends to grant rights to 
commercialize this invention to no other licensees. The patent rights 
in this invention have been assigned to the government of the United 
States of America. The invention to be licensed is:
    Title: Barricade System and Barricade Bracket for Use Therein, CDC 
Ref. : I-016-04, a safety rail system that provides protection 
to individuals working on inclined structures. The system is designed 
to prevent individuals from falls to a lower level.
    U.S. Patent No.: 7,509,702.
    U.S. Application No.: 11/257,472.
    Filing date: 10/24/2005.
    Canadian Application No.: 2,565,354.
    Filing date: October 23, 2006.
    The prospective exclusive license will be royalty-bearing and will 
comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.

ADDRESSES: Requests for a copy of this patent application, inquiries, 
comments, and other materials relating to the contemplated licenses 
should be directed to Andrew Watkins, Director, Technology Transfer 
Office, Centers for Disease Control and Prevention (CDC), 4770 Buford 
Highway, Mailstop K-79, Atlanta, GA 30341, telephone: (770) 488-8610; 
facsimile: (770) 488-8615. Applications for an exclusive license filed 
in response to this notice will be treated as objections to the grant 
of the contemplated exclusive license. Only written comments and/or 
applications for a license which are received by CDC within thirty days 
of this notice will be considered. Comments and objections submitted in 
response to this notice will not be made available for public 
inspection, and, to the extent permitted by law, will not be released 
under the Freedom of Information Act, 5 U.S.C. 552.

Tanja Popovic,
Deputy Associate Director for Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2011-10257 Filed 4-27-11; 8:45 am]
BILLING CODE 4163-18-P